vimarsana.com

Page 15 - Americas Committee News Today : Breaking News, Live Updates & Top Stories | Vimarsana

ACTRIMS 2023: Less frequent Ocrevus infusion not tied to greater MS activity | Analysis of changes made during COVID-19

Greater disease activity was not evident in MS patients given a next Ocrevus infusion at times beyond the recommended every six months.

San diegoUnited statesNicole bou rjeilyAbou rjeilyJohns hopkinsJohns hopkins universityAmericas committee for treatmentResearch in multiple sclerosisAmericas committeeMultiple sclerosisInterval dosingMultiple sclerosis is not associatedMeaningful differencesDisease activityMultiple sclerosis news today

ACTRIMS 2023: MS activity not reduced with high-dose vitamin D | Multiple Sclerosis News Today

The researchers in the VIDAMS clinical trial concluded that high-dose vitamin D3 doesn't reduce disease activity in relapsing-remitting MS.

San diegoUnited statesSandra cassardJohns hopkins universityInternational unitsEndocrine societyJohns hopkins school of medicineAmericas committee for treatmentResearch in multiple sclerosisAmericas committeeMultiple sclerosisHopkins universityJohns hopkins school

Physical Activity a Growing Priority for Patients With MS

With mounting research showing that physical activity affects brain volume, fatigue, and other outcomes, researchers are finding ways to have patients with multiple sclerosis be more active.

United statesE ann yehLos angelesMarwa kaiseyUniversity of torontoSinai medical centerAmericas committee for treatmentNeuroinflammatory disorders programResearch in multiple sclerosisSick childrenMedscape medicalAmericas committeeMultiple sclerosisBrief repeatable batteryMedscape medical newsCedars sinai medical center

Let s talk about MS fatigue and the effectiveness of treatment options | Multiple Sclerosis News Today

Columnist Ed Tobias discusses some recent findings shared at this year's ACTRIMS conference regarding MS fatigue, modafinil, and CBT.

United statesSan diegoMarisa wexlerAmericas committee for treatmentJournal of psychosomatic researchResearch in multiple sclerosisUniversity of michiganPsychosomatic researchAmericas committeeMultiple sclerosisModified fatigue impact scalePatient global impression

ACTRIMS 2023: Learning, lectures and leaving with hope | Multiple Sclerosis News Today

Jenn Powell, who lives with secondary progressive MS, sums up the ACTRIMS Forum 2023 from a patient's perspective.

Stanford universityUnited statesSan diegoLawrence steinmanRuth ann marrieCyndi zagieboyloKennethp johnsonDaniel ontanedaMitzi joi williamsTyler campbellDiego marinaNational ms societyAmericas committee for treatmentCleveland clinic mellen centerNational multiple sclerosis societyResearch in multiple sclerosis

vimarsana © 2020. All Rights Reserved.